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A new emerging genotype subgroup within PCV-2b dominates
the PMWS epizooty in Switzerland
Abstract
Postweaning multisystemic wasting syndrome (PMWS) is among the most important emerging pig
diseases worldwide. Initially, the insidious nature of the disease made it difficult to pinpoint the
pathogen. The presence of porcine circovirus type 2 (PCV2) in all PMWS diseased animals led to its
acceptance, possibly together with an unknown factor, as the causative agent for PMWS. Also, presence
of PCV2 in healthy individuals did not facilitate the understanding of the disease. Phylogenetic
classification separates PCV2 viruses into at least two major groups. With the aid of a signature motif, a
short amino acid motif encoded within the capsid protein, the viruses are determined as belonging to
PCV-2a or PCV-2b. Recently, this classification received more attention, as it seemed to define PCV-2b
to be more virulent. This simplification, however, could not be confirmed experimentally. Hence, we
investigated whether virus genetic shift was an initiator for the PMWS epizooty in Switzerland. Piglet
lymphoid tissues from 1973 to 2005 were investigated by histology, immunohistochemistry (IHC) and
PCR. For genotype classification, a sequence amplificate of 137bp was used encompassing the signature
motif. The onset of Swiss PMWS epizooty exhibited a marked shift in PMWS diseased and
subclinically infected piglets to PCV-2b and specifically to one genotype subgroup. Complementary to
these observations, healthy piglets also defined by IHC as negative are positive in the PCR reaction and
are void of any PCV-2b virus during epizooty. Consequently, our data support PCV2 genome plasticity
as a major contributing factor for PMWS disease manifestation.
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Abstract21
Postweaning multisystemic wasting syndrome (PMWS) is among the most important22
emerging pig diseases worldwide. Initially, the insidious nature of the disease made it23
difficult to pinpoint the pathogen. The presence of porcine circovirus type 2 (PCV2) in24
all PMWS diseased animals led to its acceptance, possibly together with an unknown25
factor, as the causative agent for PMWS. Also, presence of PCV2 in healthy individuals26
did not facilitate the understanding of the disease. Phylogenetic classification separates27
PCV2 viruses into at least two major groups. With the aid of a signature motif, a short28
amino acid motif encoded within the capsid protein, the viruses are determined as29
belonging to PCV-2a or PCV-2b. Recently, this classification received more attention,30
as it seemed to define PCV-2b to be more virulent. This simplification however, could31
not be confirmed experimentally. Hence, we investigated whether virus genetic shift was32
an initiator for the PMWS epizooty in Switzerland. Piglet lymphoid tissues from 1973 to33
2005 were investigated by histology, immunohistochemistry (IHC) and PCR. For34
genotype classification, a sequence amplificate of 137 bp was used encompassing the35
signature motif. The onset of Swiss PMWS epizooty exhibited a marked shift in PMWS36
diseased and subclinically infected piglets to PCV-2b and specifically to one genotype37
subgroup. Complementary to these observations, healthy piglets also defined by IHC as38
negative are positive in the PCR reaction and, are void of any PCV-2b virus during39
epizooty. Consequently, our data support PCV2 genome plasticity as a major40
contributing factor for PMWS disease manifestation.41
42
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1. Introduction45
Postweaning multisystemic wasting syndrome (PMWS) was first noticed in Canada in46
the year 1991 (Harding et al., 1996). Since then, PMWS emerged as a major source of47
economic losses in most pig-producing countries (Meehan et al., 1998; Allan and Ellis48
2000; Fenaux et al., 2004). In acute outbreaks, overall mortality can reach up to 50%49
(Cheung et al., 2007). Piglets between 5 and 12 weeks of age are most commonly50
affected (Allan and Ellis, 2000). PMWS clinical manifestations include wasting, and51
individual variable degrees of palpable enlarged lymph nodes, respiratory distress,52
anemia, diarrhea and jaundice (Allan and Ellis, 2000; Harding et al., 1996). Typical53
microscopical findings are lymphocyte depletion, histiocytic infiltrations and occurrence54
of giant cells in lymphoid tissues, sometimes basophilic intracytoplasmatical inclusions,55
as well as variable occurrence of necrotizing lymphadenitis, interstitial nephritis,56
interstitial pneumonia, hepatitis and granulomatous enteritis (Allan and Ellis, 2000;57
Segalés et al., 2004).58
Porcine circovirus type 2 (PCV2) has been implicated as the etiological agent for PMWS59
disease (Allan et al., 1999; Kennedy et al., 2000). However, PCV2 is suspected to be60
also associated with other swine diseases such as porcine respiratory disease complex,61
reproductive disorders, porcine dermatitis and nephropathy syndrome (PDNS) and62
congenital tremor (Segalés et al., 2004).63
During their life most pigs get infected with PCV2 and even seroconvert against PCV264
without ever showing any symptoms of disease (Allan and Ellis 2000; Larochelle et al.,65
42003). Likewise, PCV2 can effortlessly be isolated from seemingly “healthy” herds with66
no PMWS incidents (Larochelle et al., 2003). Hence, PMWS disease is discussed to67
have a multifactorial base (Allan et al., 1999; Allan and Ellis 2000) and among scientists68
there is a considerable debate in what triggers PMWS onset. Common to all scenarios is69
the presence of PCV2 virus. However, an additional factor is suspected in the initiation70
of PMWS. Possible triggers may be husbandry form changes, immunstimulation by71
common vaccine regimes, the occurrence of additional agent/s, either already present as72
described for example for porcine reproductive and respiratory syndrome (PRRS) or73
newly introduced agents as hypothesized in the “agent X” theory or viral genomic74
plasticity driving PCV2 virus pathogenicity (Opriessnig et al., 2007).75
Early investigations focused on identifying obvious genetic differences of PCV2 with76
conceivable correlations to PMWS. Phylogenetical observations e.g. by Larochelle et al.77
(2002), DeBoisséson et al. (2004) and Grierson et al. (2004) found large clusters with78
several clades of different PCV2 genotypes without any correlation to disease or79
regional outbreaks. Subsequent studies succeeded further to phylogenetically categorize80
PCV2 into at least two major genotypes (Carman et al., 2006; Gagnon et al., 2007;81
Olvera et al., 2007; Timmusk et al., 2008), namely PCV-2a and PCV-2b (Segalés et al.,82
2008). PCV-2a and -2b can also be distinguished by the so-called signature motif83
(Cheung et al., 2007) that encodes a distinct stretch of amino acid in the viral capsid84
protein. Nevertheless, these genotypes could not be correlated with PMWS disease85
(Olvera et al., 2007). A third genotype (PCV2c) was detected in Denmark with only86
three sequences to date (Dupont et al., 2008).87
5Recent observations support the importance of this original classification for instance in88
Canada and USA, where PCV-2b was newly detected in PMWS outbreaks of 2004,89
whereas in Europe this virus type already existed (Carman et al., 2006; Cheung et al.,90
2007; Fenaux et al., 2004; Gagnon et al., 2007; Opriessnig et al., 2007). Additionally, a91
study on a small swine cohort from Spain specifically found PCV-2b occurrence92
associated with PMWS disease (Grau-Roma et al., 2008). Interestingly, various research93
groups (Fenaux et al., 2004; Hasslung et al., 2005, Opriessnig et al., 2006) found further94
evidence for different virulence of PCV2 variants in vitro and in animal infection95
models.96
PCV2 belongs to the Circoviridae family. As such the virus is a small non-enveloped,97
isometric DNA virus that is comprised of about 1.76 kb single-stranded circular DNA.98
Within PCV2, three major open reading frames (ORFs) were detected of which the two99
larger ones encode ORF2, the capsid protein (cap) and, ORF1, the replicase protein100
(rep), representing approximately 93% of the PCV2 genome (Mankertz et al., 2000;101
Meehan et al., 1998). ORF3 was found within ORF1 and seems to be involved in virus102
induced apoptosis of host cells (Timmusk et al., 2008). The signature motif (Cheung et103
al., 2007) discriminating PCV-2a and -2b lies within the virus capsid protein, that in104
many instances contains virus pathogenicity characteristics (Fenaux et al., 2004).105
In this work, we noticed a burst of disease cases starting in late 2003 that constituted the106
beginning of PMWS epizooty in Switzerland. We present an epidemiological analysis of107
PCV2 genotype occurrence in healthy and PMWS diseased pigs. A PCR was designed108
including coding sequences of the signature motif to screen paraffin embedded109
retrospective material of Swiss pigs. PCV-2b, albeit present in the Swiss swine110
6population throughout the years investigated, is particularly associated to the epizooty.111
Within PCV-2b, we found a distinct genotype subgroup that we preliminarily named112
“PVC-2b-CH” and that dominated the occurrence in diseased animals but was absent in113
healthy piglets during PMWS epizooty.114
115
2. Material and methods116
2.1. Samples, animals117
From the archived necropsy material of the Institute of Veterinary Pathology of the118
University of Zurich, paraffin-embedded lymphoid tissues from 287 piglets of the years119
1973 through 2005 were selected and investigated by histology, immunohistochemistry120
(IHC) and PCR specific for PCV2. 163 IHC PCV2 positive animals were reviewed121
histologically and reevaluated by current available data from pathological protocols,122
anamnesis, clinical records, owner reports, veterinarian records and the Swiss Health123
Service (SGD) database. In tissue samples of 124 animals no PCV2 antigen was124
detected by IHC and thus indicated as IHC negative. PDNS cases were excluded.125
Archived lymphoid tissue from cases between 1973-2002 was limited mostly to the126
organ spleen and rarely lymph node or ileum, as PMWS did not pose a problem for127
Switzerland during this period. However, in 2001 and 2002, Staebler and colleagues128
specifically analyzed cases for PMWS, as this disease existed in Europe but outside of129
Switzerland (Borel et al., 2001; Staebler et al., 2004; Staebler et al., 2005). From 2003,130
with realization of PMWS disease occurring in Switzerland, lymphoid tissues including131
lymph nodes, tonsils, spleen and ileum were regularly collected in the routine necropsy.132
133
72.2. Statistical analysis134
Statistical calculations were performed with JMP® 7.0 for Macintosh. Unequal sampling135
(variable animal numbers per investigated farm) was probed with logistic regression and136
forced independent variables. Relevant unequal sampling was calculated, however, it137
had no influence of the data outcome. A P value of ≤ 0.05 was accepted as statistically138
significant.139
140
2.3. Case definition141
“PMWS case on individual level” was diagnosed according to the internationally142
accepted criteria including wasting, at least moderate PCV2 antigen quantity and143
lymphocyte depletion (Fig.) (www.pcvd.org; Sordon, 2000; Segalés and Domingo,144
2002). Consequently an animal with low to moderate PCV2 antigen quantity and with145
mild lymphoid lesions was defined as subclinically infected.146
At the “PMWS herd case level” diagnosis was less stringently applied, due to absence of147
mortality data after weaning and putative small number of investigated animals148
(www.pcvd.org; Opriessnig et al., 2007). For “PMWS herd case” at least one animal had149
to be PMWS diseased together with available information from farmers and clinicians150
concerning wasting problems.151
152
2.4. Immunohistochemistry (IHC)153
We used clone F217 monoclonal antibody for IHC (McNeilly et al., 2001) on fixed154
paraffin-embedded lymphoid tissues (Staebler et al., 2005). Briefly, 3 µm thick sections155
were paraffin depleted with xylene and gradually alcohol dehydrated before incubation156
8with pronase (S2019, Dako, Glostrup, Denmark). Consequently, F217 hybridoma157
supernatant was diluted 1:2 and incubated for 60 min with each section. Following158
endogenous peroxidase activity neutralization (S2023, Dako), the secondary dextran-159
bound peroxidase-conjugated goat anti-mouse antibody was applied (Envision-Kit160
Mouse/Rabbit K5007, DakoCytomation) for 30 min. The detection step was performed161
with amino-ethyl-carbazol (Dako) for 10 min. Finally the sections were counterstained162
with Mayer’s hematoxylin. The immunohistochemical analysis was carried out in the163
Dako Autostainer at room temperature.164
165
2.5. DNA isolation166
DNA was extracted using DNeasy® Blood & Tissue kit (250) from Qiagen (Qiagen167
69506, Hombrechtikon, Switzerland).168
169
2.6. Primer design170
We designed a PCV2 specific PCR primer pair in the ORF2. 16 PCV2 genomes from 12171
different countries (Accession numbers: AF201311 Germany, AY745018 Australia,172
AY874169 Hungary DQ233257 Romania, AB072301 Japan, NC005148 Austria,173
AY864814 Thailand, AY672600 South Korea, AF264043 USA, AF118097 Canada,174
AF201309 Germany, AY391993 France, AY129155 USA, DQ231518 China,175
DQ195679 China, AY484416 GB) were aligned with PCV1 (AY193712.1) sequence176
using the web based alignment software “Multalin” (Corpet, 1988). Primers were chosen177
in a conserved sequence flanking a heterogenous region (137 bp DNA-fragment178
excluding primers) within ORF2.179
9Primers: PCV2 F 5’- CGYTGGAGAAGGAAAAAYGGC - 3’ (21 bp)180
PCV2 R 5’- GTAGTATTCAAAGGGYAYAGAG - 3’ (22 bp)181
182
2.7. PCR reaction conditions183
PCR was carried out using FastStart Taq DNA polymerase Roche mastermix in a 50 µl184
final reaction volume. The mastermix contains per reaction 40 µl deionized water, 5 µl185
10x PCR reaction buffer and 20 mM MgCl2, 2 µl 10 mM dNTP (Roche), 0.5 µl of each186
primer, 2 U Taq polymerase and 1 µl template. PCR reactions were performed in the PE187
GeneAmp 9700 Cycler (PE/Applied Biosystems) with 5 min activation of FastStart Taq188
DNA polymerase at 96 °C, 30 sec template denaturing at 95 °C, 30 sec primer annealing189
at 52 °C and 30 sec elongation at 72 °C for 40 cycles. Amplification completion was190
achieved at 72 °C for 10 min. Amplified PCR products were analyzed by agarose-gel191
electrophoresis. By using the Qiagen gel purification kit (MinElute® PCR Purification192
Kit (28004)) PCR products were purified and sequenced (3130XL ABI, Applied193
Biosystems).194
195
2.8. PCR condition optimization196
For PCR reaction optimization a PCV2 amplificate (DQ 923523 / 24) from a 2004197
diseased piglet was directly ligated into the TA cloning vector pCR® 2.1 TOPO®198
according to TOPO® TA manual (Invitrogen). Correct amplification size was verified199
with an EcoR I endonuclease restriction digest and amplified product sequenced.200
Dilution series of this plasmid were used for PCR optimization and positive controls.201
We found this PCR reaction detects as low as one template virus genome per µl input.202
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2.9. Definition of genotype subgroups within PCV-2a, PCV-2b and PCV-2c by in silico204
analysis205
The obtained sequences were compared to the NCBI GenBank databases available206
PCV2 sequences by using the BlastN program in March 2007. The alignments for207
amino acid or nucleotide sequences were accomplished with MAFFT multiple208
alignment program (version 5.8).209
The PCR amplificate of 137bp excluding oligonucleotide sequences distinguishes PCV-210
2a and PCV-2b genotypes mainly by the signature sequence. However, PCV-2c by this211
criteria is undistinguishable to PCV-2b genotype. To keep nomenclature simple we refer212
only to PCV-2b instead of both PCV-2b and PCV-2c.213
We further divide PCV-2a and PCV-2b genotypes according to PCR amplificate214
sequences into genotype subgroups by two criteria: i) genotype subgroups are at least215
one nucleotide in the amplificates divergent from one another and ii) genotype216
subgroups identified under i) need to be at least one amino acid different outside the217
amplificate in the ORF2 coding sequences found in the NCBI database. Finally,218
genotype subgroup name was given according to accession number from first complete219
genome that appeared during Blast comparison of NCBI database in March 2007 with220
the received amplificate sequence.221
222
3. Results223
3.1. PCV2 infection accessed by histology and IHC224
11
287 piglets were investigated, of which 163 were IHC positive and 124 negative. 98 of225
the 163 IHC positive animals showed at least a moderate quantity of PCV2 antigen226
(Fig.), of these 93 were diagnosed as PMWS diseased due to lymphoid lesions and227
wasting and 5 were found subclinically infected because they showed neither wasting228
nor lymphocyte depletion. Tissue samples of the remaining 65 animals contained low229
PCV2 antigen quantities. 64 with none to mild lymphocyte depletion were categorized230
as subclinically infected. One had severe lymphocyte depletion, histiocytic infiltration231
and occurrence of giant cells albeit with low quantities of PCV2 antigens; however as it232
wasted similar to the other PMWS cases, it was grouped as PMWS diseased. Lesions233
and antigen quantities are described in table 1.234
The first discovered IHC positive case originated from 1986 and showed severe235
depletion as well as histiocytic infiltration (Fig.). Although the number of diseased cases236
with severe lesions increased in the epizooty, no marked change of the characteristics of237
lesions (lymphocyte depletion, histiocytic infiltrations, multinucleated giant cells,238
inclusion bodies) could be observed with time.239
The distribution of diseased and subclinically infected animals over time is listed in table240
2. None of the 124 IHC negative tissues showed histological lesions.241
242
3.2. PCR findings243
All samples were examined by PCR. The first PCR positive case was detected from244
1979. While PCV2 sequences were identified in all IHC positive animals (n = 163) by245
PCV2 specific PCR reaction, in 51 (42%) of the IHC negative (n = 124) animals PCV2246
sequences were also detected.247
12
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3.3. Sequence findings249
DNA preparations from tissues of 163 IHC positive and 51 IHC negative animals were250
PCR amplified and product sequenced. Analysis of the 214 cases resulted in 13 DNA251
sequences with at least one nucleotide difference. NCBI database investigation revealed252
more than one accession number 100% identical to each sequence.  According to our253
definition of genotype subgroups  (Chapter 2.9), we designated 12 different genotype254
subgroups because the two accession numbers, DQ923523 (Brazil) and DQ923524255
(Brazil), contain a nucleotide polymorphism in the amplified PCR sequence, but they256
encode the same amino acids in the capsid protein. For simplification we combined257
sequences identical to DQ923523 (Brazil) and DQ923524 (Brazil) in the PCR product to258
one genotype subgroup we named PCV-2b-CH. The following 11 accession numbers259
were used as genotype subgroup names: AY754016 (Australia), AF109398 (China),260
AY754018 (Australia), AY754021 (Australia), AF264040 (USA), AF381176 (China),261
AF381177 (China), AY713470 (Germany) DQ180392 (China), DQ220737 (Canada)262
and AY322003 (China). With aid of the signature motif (Cheung et al., 2007) we263
identified 7 genotype subgroups belonging to PCV-2a and 5 belonging to PCV-2b264
(Table 2).265
In IHC negative animals, we found a reduced variety of the already discovered PCV2266
genotype subgroups, identified as 5 of the 7 PCV-2a genotype subgroups and 1 of the 5267
PCV-2b genotype subgroups (Table 3). 98 pre-epizootic and 26 epizootic IHC negative268
animals were analyzed. 31 pigs carried DNA from PCV-2a genotype subgroups and 20269
13
from PCV-2b genotype subgroups. The existence of PCV-2b-CH in IHC negative270
animals can be dated back to 1979.271
272
3.3.1. PCV2 genotype subgroups in IHC positive lymphoid tissues correlated to time273
163 PCR products were correlated to 12 PCV2 genotype subgroups of which infected274
hosts were analyzed with histology and IHC to define the animal status as diseased or275
subclinically infected over time. PCV2 sequences of animals from 1986 to 2003 showed276
that 43 harbored PCV-2a genotype subgroup members and 15 PCV-2b genotype277
subgroup members. From late 2003 to 2005 PCV2 genotype subgroup frequency278
reversed. Of the pigs analyzed, 10 harbored PCV-2a genotype subgroups and 95 PCV-279
2b genotype subgroups  (P chi-square < 0.0001).280
With the genotype shift the diseased cases and affected farm frequency increased281
dramatically. Prior to 2004, PCV-2a viruses were found in sporadic “PMWS herd cases”282
limited to three small farms of which two were not professionally managed and in one of283
these farms two different genotype subgroups were found (Table 2). A “PMWS herd284
case” due to PCV-2b appeared for the first time in 2002 in a professionally managed285
farm more than one year before the onset of the Swiss PMWS epizooty. However,286
following the epizooty onset, this particular PCV-2b genotype subgroup (AY322003)287
was not detected. Subsequently, after late 2003 PCV-2b infection in affected farms288
increased to a total of 26 and none was found to be PCV-2a infected (Table 2). Of note,289
piglets infected with PCV-2b had 306 times higher probability to PMWS disease after290
late 2003 (Odds ratio = 0.0033, P chi-square < 0.0001).291
14
The first diseased animal with PCV-2b infection was observed in 1999 without any292
associated herd problem. However, PCV-2b subclinically infected IHC positive animals293
were dated back to 1989 (Table 2).294
Associated to the increase of diseased animals was virtually one genotype subgroup,295
PCV-2b-CH (Table 2). PMWS diseased animals infected with PCV-2b-CH increased296
from 1 pre-epizootic to 69 in the epizooty whereas the number of animals infected with297
other genotype subgroups decreased from 20 to 4 (P chi-square < 0.0001). Additionally, the298
logistic regression indicates a 345 times higher risk for PCV-2b-CH (P chi-square < 0.0001)299
infected animals to be diseased during epizooty. In analogy we found a PCV2 genotype300
subgroup shift to PCV-2b-CH among subclinically infected IHC positive animals. Both301
observations point to a PCV2 genetic drift.302
303
3.3.2. PCV2 genotype subgroups in IHC negative lymphoid tissues correlated to time304
Of the 51 PCR positive IHC negative cases, 42 originated pre-epizootic and 9 within the305
epizooty.  In the pre-epizootic period, 20 cases could be allocated to PCV-2b and 22 to306
PCV-2a. Within the epizootic period, PCV-2a genotype subgroups were solely detected307
(Table 3).308
Among IHC negative lymphoid tissues we found the exclusive presence of PCV-2b-CH309
within PCV-2b. After the PMWS outbreak none of the animals carried PCV-2b-CH (P310
Fisher's exact chi-square < 0.008). These data are complementary to the IHC positive lymphoid311
tissue studies presented.312
313
5. Discussion and Conclusions314
15
PMWS is among the most important emerging pig diseases worldwide (Allen et al.,315
2007). In piglets, disease manifestation is always associated with PCV2 occurrence316
(Allan et al., 1999; Kennedy et al., 2000). Unexpectedly, PCV2 was also found in a317
different host, namely in bovine (Nayar et al., 1999; our own observations). This, after318
all, is not surprising as PCV2 is difficult to eradicate from the environment. Its319
robustness is noticed by e.g., the slight drop of 0.75 log in virus infectivity at 80 °C for320
72 hours or, the reduced infectivity by about 18 times (Opriessnig et al., 2007) at 120 °C321
dry heat for 30 min. Its stability and intrinsic capability to resist adverse conditions may322
allow survival time for this single stranded virus to evolve and adapt to host. These323
characteristics give the virus a unique edge over the host defense system.324
This study includes the occurrence of PCV-2a and PCV-2b as well as their genotype325
subgroups from 1973-2005 and also covers the onset of Swiss epizooty in late 2003. We326
discriminated between PMWS diseased and PCV2 subclinically infected animals before327
and after the PMWS epizooty. Simultaneously, we developed a PCR, which included the328
signature motif (Cheung et al., 2007) as well as heterogeneous nucleotide sequences to329
further discriminate different genotype subgroups. The amplificate had to be short (137330
bp excluding flanking primers) in order to screen paraffin embedded material.331
The diagnosis of a “PMWS case on individual level” was defined according to332
internationally accepted criteria (www.pcvd.org; Segalés and Domingo, 2002; Sordon333
2000). However, absence of mortality data after weaning and putative small number of334
investigated animals led to less restrictive categorization for “PMWS herd case” than the335
EU (www.pcvd.org) or US (Opriessnig et al., 2007) definitions.336
16
The epizooty onset in Switzerland was observed in late 2003 with subsequent massive337
PMWS cases increase in the routine necropsy (Table 2). Concurrently, SGD and338
clinicians also reported an increase in PMWS herd manifestations. Indeed, in the years339
before 2004 few PMWS herd cases and few single diseased animals were noted in340
Switzerland (Borel et al., 2001; Staebler et al., 2004; Staebler et al., 2005). Additionally,341
supporting data from Staebler et al. (2004), revealed no significant PMWS involvement342
in pig wasting problems in the pre-epizootic period. However, our observations show343
PCV2 infection in the pre-epizootic time period occurred mainly with subclinical disease344
patterns.345
Prior to PMWS epizooty, as far as we were able to determine, no risk factors that are346
suspected to trigger PMWS, significantly changed or newly occurred in Switzerland.347
Some suspected risk factors were not even observed seeing that Switzerland is free from348
pig diseases listed by the Office International des Epizooties including Aujeszky's349
disease and porcine reproductive and respiratory syndrome (PRRS) (Corbellini et al.,350
2006). Furthermore, enzootic mycoplasmal pneumonia and contagious351
pleuropneumonia, notifiable diseases since 1995, are nearly eliminated (re-infection352
rates lower than 1% (Staerk et al., 2007)) and the law forbids vaccination against them.353
Porcine parvovirus (PPV) is present but vaccinated. There were no alterations in the354
genetic background of Swiss pig population between pre-epizootic and epizootic355
periods. Although general animal husbandry may have undergone slight modifications,356
we suggest that it cannot be a major contributing factor to PMWS epizooty, as small size357
of Swiss breeding farms do not apply in comparison to European Union farms. As a358
17
result, we suspect PCV2 genetic plasticity to be a main risk factor to the Swiss PMWS359
epizooty.360
In our observations, the epizooty in Switzerland was highly correlated with dominance361
of PCV-2b viruses in diseased or moderate antigen containing subclinically infected362
animals. Of significance is that PCV-2b viruses did not newly arise in the Swiss pig363
population in contrast to the recent PMWS epizooties in USA, Canada and Denmark364
(Carman et al., 2006; Cheung et al., 2007; Dupont et al., 2008; Opriessnig et al., 2007).365
They were undeniably present in healthy IHC negative animals at least from 1979. Also,366
we found PCV-2a causing sporadic PMWS cases. Furthermore, PCV-2a or -2b viruses367
were not discriminated between diseased and healthy animals before late 2003.368
Interestingly, in the epizooty, we noted a shift to PCV-2b viruses. On closer analysis of369
PCV-2b, we discovered a dominant genotype subgroup, PCV-2b-CH, which was370
definitely absent in healthy IHC negative individuals after 2003. Based on our review of371
the NCBI database, we predict that this genotype subgroup may include at least 31372
different viruses. These viruses are clearly distinguishable from the other PCV-2b373
viruses. Thus, these findings need further detailed investigations.374
The Swiss epizooty gives us a unique opportunity to develop our thesis that a main375
factor leading to PMWS development may be the enhancement of virulence of particular376
PCV2 viruses within PCV-2b-CH. We hypothesize that the pre-existence of PCV-2b-CH377
in healthy individuals dating back to 1979 may have provided the critical genetic pool378
for enhanced virulence, which is attributed to the relevant nucleotide exchanges that379
occurred by a genetic drift around the epizooty. We also speculate that this situation380
occurred in other countries. Reflecting on the observations of the disease spread, it381
18
seems to be consistent with the introduction of an infectious agent into a naïve382
population (Vigre et al., 2005). This may explain the “factor X theory”. However, owing383
to the high stability of the virus in the environment, animal-to-animal contact may not be384
a prerequisite for the spread of PCV-2b-CH virulent viruses observed in the epizooty385
(Dupont et al., 2007).386
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519
IHC quantity Number
of
animals
PMWS
diseased
Lymphocyte
depletion
Histiocytic
infiltration
Giant cells Inclusion
bodies
Yes No Yes No Yes No Yes No Yes No
High 51 51 - 51 - 40 11 20 31 15 36
Moderate 47 42 5 42 5 35 12 22 25 4 43
Low 65 1 64* 35 30 23 42 8 57 1 64
520
Table 1: Histological lesions of the IHC positive animal cases. The 163 IHC positive521
cases compiled in view of PMWS disease and histological characteristics. (* No522
to moderate depletion.  Low quantity of PCV2 antigen limited to inclusion523
bodies)524
525
27
526
Table 2: Statistically, highly significant genetic shift to PCV-2b viruses, in particular to527
PCV-2b-CH (*) at the start of epizooty. The study shows genotype subgroup528
analysis of IHC positive animal cases before and during epizooty of diseased ( )529
or subclinically infected () animals that were categorized by time occurrence.530
PMWS herds are indicated with ′, in one herd (′#, year 2000) two different531
genotype subgroups have been found. The animal health status was defined by532
histology, IHC and clinic followed by virus genotype determination by PCR of a533
short DNA sequence within the PCV2 capsid protein region. (n) refers to534
analyzed animals.535
28
536
537
Table 3: Subclinical PCV2 infected healthy piglets are completely void of any PCV-2b538
or the more specific genotype subgroup PCV-2b-CH (*) in epizooty. Healthy539
IHC negative piglets (), subclinically infected with PCV2 were analyzed by540
29
PCR specific for PCV2 and the genotype subgroups presented in correlation to541
time. (n) refers to analyzed animals and (x) to PCR positive cases.542
543
30
544
31
Fig.: Case definitions according to PCV2 antigen amount and lymphatic depletions.545
Hematoxilyn-Eosin stained tissue slices (1, 2, 3) and IHC positive (A, B, C) case546
examples with 1, no lymphatic depletion in lymph node and A, low amount of547
PCV2 antigen; 2, mild lymphatic depletion and B, moderate amounts of PCV2548
antigen and 3, severe lymphatic depletion and C, abundant PCV2 antigen. The549
interpretation together with the clinic define 1, A as subclinically infected, 2, B550
and 3, C as PMWS diseased.551
